In vivo neutralization of hepatitis B virus infection by an anti-preS1 humanized antibody in chimpanzees

Virology

Volumn 318, Issue 1, 2004, Pages 134-141

  Hong, Hyo Jeong ^a   Ryu, Chun Jeih ^a   Hur, Hyangsuk ^a   Kim, Seho ^b   Oh, Han Kyu ^b   Oh, Mee Sook ^c   Park, Song Yong ^b  

^a Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

^b Green Cross Company   (South Korea)

^c Aprogen Inc   (South Korea)

Author keywords

Chimpanzee; Hepatitis B virus; Humanized antibody; Neutralization; preS1

Indexed keywords

ANTIBODY PRE S1; KR 127; MONOCLONAL ANTIBODY; NEUTRALIZING ANTIBODY; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHIMPANZEE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG SCREENING; HEPATITIS B; HEPATITIS B VIRUS; IMMUNOPROPHYLAXIS; IN VIVO STUDY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; VIRUS NEUTRALIZATION; WILD TYPE;

HEPATITIS B VIRUS; MURINAE; PAN (APE); PAN TROGLODYTES;

EID: 1242274575     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.virol.2003.09.014     Document Type: Article

References (40)

1. Beasley R.P., Hwang L.Y., Lee C.Y., Lan C.C., Roan C.H., Huang F.Y., Chen C.L. Prevention of perinatally transmitted hepatitis B virus infection with hepatitis B immune globulin and hepatitis B vaccine. Lancet. 2:1983;1099-1102.
2. Bhatnager P.K., Papas E., Blum H.E., Milich D.R., Nitecki D., Kareb M.J., Vyas G.N. Immune response to synthetic peptide analogues of HBsAg specific for the a determinant. Proc. Natl. Acad. Sci. U.S.A. 79:1982;4723-4727.
3. Courouce A.M., Lee H., Drouet J., Canavaggio M., Soulier J. Monoclonal antibodies to HBsAg: a study of their specificities for eight different HBsAg subtypes. Dev. Biol. Stand. 54:1982;527-534.
4. De Falco S., Ruvoletto M.G., Verdoliva A., Ruvo M., Raucci A., Marino M., Senatore S., Cassani G., Alberti A., Pontisso P., Fassina G. Cloning and expression of a novel hepatitis B virus-binding protein from HepG2 cells. J. Biol. Chem. 276:2001;36613-36623.
5. Dreesman G.R., Sanchez Y., Ionescu-Matiu I., Sparrow J.T., Six H.R., Peterson D.L., Hollinger F.B., Melnick J.L. Antibody to hepatitis B surface antigen after a single inoculation of uncoupled synthetic HBsAg peptides. Nature (London). 295:1982;158-160.
6. Eren R., Ilan E., Nussbaum O., Lubin I., Terkieltaub D., Arazi Y., Ben-Moshe O., Kitchinzky A., Berr S., Gopher J., Zauberman A., Galun E., Shouval D., Daudi N., Eid A., Jurim O., Magnius L.O., Hammas B., Reisner Y., Dagan S. Preclinical evaluation of two human anti-hepatitis B virus (HBV) monoclonal antibodies in the HBV-trimera mouse model and in HBV chronic carrier chimpanzees. Hepatology. 32:2000;588-596.
7. Fujii H.K., Moriyama K., Sakamoto N., Kondo T., Yasuda K., Hiraizumi Y., Yamazaki M., Sakaki Y., Okochi K., Nakajima E. Gly145 to Arg substitution in HBs antigen of immune escape mutant of hepatitis B virus. Biochem. Biophys. Res. Commun. 184:1992;1152-1157.
8. Galun E., Eren R., Safadi R., Ashour Y., Terrault N., Keeffe E.B., Matot E., Mizrachi S., Terkieltaub D., Zohar M., Lubin I., Gopher J., Shouval D., Dagan S. Clinical evaluation (phase I) of a combination of two human monoclonal antibodies to HBV: safety and antiviral properties. Hepatology. 35:2002;673-679.
9. Heermann N., Goldmann U., Schwartz W., Seyffarth T., Baumgarten H., Gerlich W. Large surface proteins of hepatitis B virus containing the pre-S sequence. J. Virol. 52:1984;396-402.
10. Heermann K.-H., Kruse F., Seifer M., Gerlich W.H. Immunogenicity of the gene S and pre-S domains in hepatitis B virions and HBsAg filaments. Intervirology. 28:1987;14-25.
11. Heijtink R., Paulij W., van Bergen P., van Roosmalen M., Rohm D., Eichentopf B., Muchmore E. In vivo activity of a mixture of two human monoclonal antibodies (anti-HBs) in a chronic hepatitis B virus carrier chimpanzee. J. Gen. Virol. 80:1999;1529-1535.
12. Itoh Y., Takai E., Ohnuma H., Kitayima K., Tsuda F., Machida A., Mishiro S., Nakamura T., Miyakawa Y., Mayumi M. A synthetic peptide vaccine involving the product of the preS2 region of hepatitis B virus: protective efficacy in chimpanzees. Proc. Natl. Acad. Sci. U.S.A. 83:1986;9174-9178.
13. Kabat, E.A., Wu, T.T., Perry, H.M., Gottesman, K.S., Foeller, C., 1991. Sequences of proteins of immunological interest. Department of Health and Human Services, Public Health Service, National Institutes of Health. NIH Publication 91-3242.
14. Kim H.S., Hong H.J. Efficient expression, purification and characterization of hepatitis B virus preS1 protein from Escherichia coli. Biot. Lett. 17:1995;871-876.
15. Klinkert M.Q., Theilmann L., Pfaff E., Schaller H. Pre-S1 antigens and antibodies early in the course of acute hepatitis B virus infection. J. Virol. 58:1986;522-525.
16. Kohno H., Inoue T., Tsuda F., Okamoto H., Akahane Y. Mutations in the envelope gene of hepatitis B virus variants co-occurring with antibody to surface antigen in sera from patients with chronic hepatitis B. J. Gen. Virol. 77:1996;1825-1831.
17. Maeng C.Y., Ryu C.J., Gripon P., Guguen-Guillouzo C., Hong H.J. Fine mapping of virus-neutralizing epitopes on Hepatitis B virus preS1. Virology. 270:2000;9-16.
18. McGory R.W., Ishitani M.B., Oliveira W.M., Stevenson W.C., McCullough C.S., Dickson R.C., Caldwell S.H., Pruett T.L. Improved outcome of orthotopic liver transplantation for chronic hepatitis cirrhosis with aggressive passive immunization. Transplantation. 61:1996;1358-1364.
19. McMahon G., Ehrlich P.H., Moustafa Z.A., McCarthy L.A., Dottavio D., Tolpin M.D., Nadler P.I., Ostberg L. Genetic alterations in the gene encoding the major HBsAg: DNA and immunological analysis of recurrent HBsAg derived from monoclonal antibody-treated liver transplant patients. Hepatology. 15:1992;757.
20. Milich D.R. Genetic and molecular basis for T- and B-cell recognition of hepatitis B viral antigens. Immunol. Rev. 99:1987;71-103.
21. Neurath A.R., Kent S.B.H., Strick N., Parker K. Identification and chemical synthesis of a host cell receptor binding site on hepatitis B virus. Cell. 46:1986;429-436.
22. Neurath A.R., Seto B., Strich N. Antibodies to synthetic peptides from the preS1 region of the hepatitis B virus envelope proteins are virus-neutralizing and protective. Vaccine. 7:1989;234-236.
23. Ogata N., Ostberg L., Ehrlich P.H., Wong D.C., Miller R.H., Percell R.H. Markedly prolonged incubation period of hepatitis B in a chimpanzee passively immunized with a human monoclonal antibody to the α determinant of hepatitis B surface antigen. Proc. Natl. Acad. Sci. U.S.A. 90:1993;3014-3018.
24. Ou J.H., Rutter W.J. Regulation of secretion of the hepatitis B virus major surface antigen by the preS-1 protein. J. Virol. 61:1987;782-786.
25. Persing H.H., Varmus H.E., Ganem D. Inhibition of secretion of hepatitis B surface antigen by a related presurface polypeptide. Science. 234:1986;1388-1391.
26. Pontisso P., Ruvoletto M.G., Gerlich W.H., Heerman K.H., Bardini R., Alberti A. Identification of an attachment site for human liver plasma membranes on hepatitis B virus particles. Virology. 173:1989;522-530.
27. Queen C., Schneider W.P., Selick H.E., Payne P.W., Landolfi N.F., Duncan J.F., Avdalovic N.M., Levitt M., Junghans R.P., Waldmann T.A. A humanized antibody that binds to the interleukin 2 receptor. Proc. Natl. Acad. Sci. U.S.A. 86:1989;10029-10033.
28. Reichert J.M. Monoclonal antibodies in the clinic. Nat. Biotechnol. 19:2001;819-822.
29. Riechmann L., Clark M., Waldmann H., Winter G. Reshaping human antibodies for therapy. Nature. 332:1988;323-327.
30. Ryu C.J., Jin B.R., Chung H.K., Han M.H., Hong H.J. Cloning and characterization of cDNAs coding for heavy and light chains of a monoclonal antibodies specific for the S antigen of hepatitis B virus. Gene. 1244:1994;313-314.
31. Ryu C.J., Padlan E.A., Jin B.R., Yoo O.J., Hong H.J. A humanized antibody with specificity for Hepatitis B surface antigen. Hum. Antib. Hybridomas. 7:1996;113-122.
32. Ryu C.J., Cho D.-Y., Gripon P., Kim H.S., Guguen-Guillouzo C., Yoo O.J., Hong H.J. An 80-kilodalton protein that binds to the pre-S1 domain of hepatitis B virus. J. Virol. 74:2000;110-116.
33. Ryu C.J., Kim Y.K., Hur H., Oh J.M., Kang Y.J., Hong H.J. Production of mouse monoclonal antibodies to hepatitis B virus preS1 by immunization with recombinant preS1 peptide. Hybridoma. 9:2000;185-189.
34. Sawyer R.G., McGory R.W., Gaffey M.J., McCullough C.C., Shephard B.L., Houlgrave C.W., Ryan T.S., Kuhns M., McNamara A., Caldwell S.H., Abdulkareem A., Pruett T.L. Improved clinical outcomes with liver transplantation for hepatitis B-induced chronic liver failure using passive immunization. Ann. Surg. 227:1998;841-850.
35. Shawler D.L., Bartholomew R.M., Smith L.M., Dillman R.O. Human immune response to multiple injections of murine monoclonal IgG. J. Immunol. 135:1985;1530-1535.
36. Stibbe W., Gerlich W. Structural relationships between minor and major proteins of hepatitis B surface antigen. J. Virol. 46:1983;626-628.
37. Tabor E., Purcell R.H., London W.T., Gerety R.J. Use of and interpretation of results using inocula of hepatitis B virus with known infectivity titers. J. Infect. Dis. 147:1983;531-534.
38. Terrault N.A., Zhou S., Combs C., Hahn J.A., Lake J.R., Roberts J.P., Ascher N.L., Wright T.L. Prophylaxis in liver transplant recipients using a fixed dosing schedule of hepatitis B immunoglobulin. Hepatology. 24:1996;1327-1333.
39. Terrault N.A., Zhou S., McCory R.W., Pruett T.L., Lake J.R., Roberts J.P., Ascher N.L., Wright T.L. Incidence and clinical consequences of surface and polymerase gene mutations in liver transplant recipients on hepatitis B immunoglobulin. Hepatology. 28:1998;555-561.
40. Tiollais P., Buendia M.A. Hepatitis B virus. Sci. Am. 264:1991;48-54.